Page last updated: 2024-09-04

ws 79089b and Heart Failure

ws 79089b has been researched along with Heart Failure in 5 studies

*Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. [MeSH]

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujii, M; Kinoshita, M; Matsumoto, T; Ohnishi, M; Tsutamoto, T; Wada, A; Wang, X; Yamamoto, T1
Emoto, N1
Fukai, D; Kinoshita, M; Maeda, Y; Ohnishi, M; Sawaki, M; Tsutamoto, T; Wada, A1
Ergul, A; Grubbs, AL; Spinale, FG; Zhang, Y1
Fujii, M; Kinoshita, M; Kurokawa, K; Matsumoto, T; Ohnishi, M; Sawaki, M; Tsutamoto, T; Wada, A; Wang, X; Yamada, H; Yamamoto, T1

Reviews

1 review(s) available for ws 79089b and Heart Failure

ArticleYear
[Physiological and pathophysiological roles of the endothelin converting enzymes].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 9

    Topics: Animals; Aspartic Acid Endopeptidases; Benzazepines; Benzofurans; Drug Design; Endothelin-Converting Enzymes; Glycopeptides; Heart Failure; Humans; Hypertension; Metalloendopeptidases; Mice; Mice, Knockout; Myocardial Infarction; Organophosphonates; Phenylalanine; Tetracyclines; Tetrazoles

2004

Other Studies

4 other study(ies) available for ws 79089b and Heart Failure

ArticleYear
Chronic effects of an endothelin-converting enzyme inhibitor on cardiorenal and hormonal function in heart failure.
    Clinical science (London, England : 1979), 2002, Volume: 103 Suppl 48

    Topics: Aldosterone; Animals; Aspartic Acid Endopeptidases; Atrial Natriuretic Factor; Cardiac Output; Cardiac Pacing, Artificial; Dogs; Endothelin-Converting Enzymes; Enzyme Inhibitors; Glomerular Filtration Rate; Heart Failure; Metalloendopeptidases; Models, Animal; Pulmonary Wedge Pressure; Renal Circulation; Tetracyclines

2002
Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
    Circulation, 1999, Feb-02, Volume: 99, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Azepines; Blood Pressure; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Female; Heart; Heart Failure; Hemodynamics; Indoles; Kidney; Male; Neuropeptides; Pulmonary Wedge Pressure; Receptor, Endothelin A; Tetracyclines; Time Factors; Vascular Resistance

1999
Selective upregulation of endothelin converting enzyme-1a in the human failing heart.
    Journal of cardiac failure, 2000, Volume: 6, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Aspartic Acid Endopeptidases; Cardiomyopathy, Dilated; Case-Control Studies; Endothelin-Converting Enzymes; Gene Expression Regulation; Heart Failure; Heart Transplantation; Heart Ventricles; Humans; Metalloendopeptidases; Phenylalanine; Reverse Transcriptase Polymerase Chain Reaction; Tetracyclines; Thiophenes; Up-Regulation

2000
Endothelin-1 promotes vascular structural remodeling during the progression of heart failure prevention of vascular remodeling using a specific endothelin-converting enzyme inhibitor.
    Life sciences, 2001, Oct-12, Volume: 69, Issue:21

    Topics: Animals; Aspartic Acid Endopeptidases; Dogs; Endothelin-1; Endothelin-Converting Enzymes; Endothelium, Vascular; Enzyme Inhibitors; Female; Heart Failure; Hemodynamics; Immunohistochemistry; Male; Metalloendopeptidases; Tetracyclines

2001